Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies

An FDA alert about a cluster of Streptococcus endophthalmitis infections in Florida suggests concerns about aseptic conditions in pharmacies that repackage Avastin for off-label intravitreal use.

More from Archive

More from Pink Sheet